CT

Chemomab Therapeutics

CMMB

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-14.74M

EBITDA$-24.1M

EBIT$-13.95M

Pre-tax Income$-9M

Net Income$-13.95M

Balance Sheet

Cash Equivalent$5.67M

Total Debt$354K

Book Value$13.29M

Book Value Per Share0.04

Key Ratios

Return on Equity (ROE)-103.01%

Return on Assets (ROA)-82.20%

Return on Invested Capital (ROI)-103.01%

Net Profit Marginundefined

Current Ratio4.98

Quick Ratio4.46

Long-Term Debt / Equitynull